Cem Sezer

65 papers receiving 863 citations

Peers

Cem Sezer
Comparison fields: 5 of 91
  • Dermatology 113
  • Clinical Biochemistry 83
  • Oncology 232
  • Neurology 67
  • Cancer Research 93
Replace Renhua Na with:
Renhua Na Australia
Won Kyu Kim South Korea
Tania Silvestri Italy
I‐Ping Chiang Taiwan
Huiyuan Zhu China
Jens Gerwien Denmark
Tomohiro Kato Japan
Fumitaka Terabe Japan
Joon Ho Lee South Korea
Salma Kotti France
Cem Sezer relative to Renhua Na Australia Renhua Na's profile →
Citations per field
00.5×10×13.4×
Renhua Na · 1×
Citations per year

Countries citing papers authored by Cem Sezer

Since Specialization
Citations

This map shows the geographic impact of Cem Sezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Sezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Sezer more than expected).

Fields of papers citing papers by Cem Sezer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Sezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Sezer. The network helps show where Cem Sezer may publish in the future.

Co-authors

The 25 scholars most cited alongside Cem Sezer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cem Sezer Line = papers co-authored together Cem Sezer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200398
2 201463
3 201449
4 200443
5 201339
6 200136
7 200236
8 201331
9 200325
10 200324
11 201323
12 200622
13 201220
14 200118
15 201317
16
The predictive role of Bcl-2 expression in operable locally advanced or metastatic gastric carcinoma.
201217
17 200516
18 201516
19 200214
20 201713

About Cem Sezer

Cem Sezer is a scholar working on Oral Surgery, Clinical Biochemistry, Oncology, Pathology and Forensic Medicine and Surgery, having authored 73 papers that have together received 899 indexed citations. Recurring topics across this work include Gestational Trophoblastic Disease Studies (6 papers), Cancer-related Molecular Pathways (6 papers), Oral and Maxillofacial Pathology (6 papers), Corneal Surgery and Treatments (4 papers), Barrier Structure and Function Studies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer-related molecular mechanisms research (4 papers) and Head and Neck Anomalies (3 papers). The work is most often cited by research in Dermatology (113 citations), Clinical Biochemistry (83 citations), Oncology (232 citations), Neurology (67 citations) and Cancer Research (93 citations). Cem Sezer has collaborated with scholars based in Türkiye, United States and Japan. Frequent co-authors include Reha Yavuzer, Gülen Akyol, Dinç Süren, Ferda Bir, Ahmet Sarı, Yavuz Başterzi, Kamil Bïlgïhan, Berati Hasanreisoğlu, Mustafa Yıldırım and Özgür Aydın. Their work appears in journals such as Pathology & Oncology Research, Pathology International, Eye, Dermatologic Surgery and Ophthalmologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026